Anthony Quinn Insider Trading $GBIO Generation Bio Co.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Anthony Quinn.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Anthony Quinn. Anthony Quinn is EVP, CMO & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and EVP, CMO, & Head of R&D in SYNAGEVA BIOPHARMA CORP ($GEVA) and Director in Aeglea BioTherapeutics, Inc. ($AGLE) and Interim CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and interim Chief Medical Officer in Aeglea BioTherapeutics, Inc. ($AGLE) and President & CEO in Aeglea BioTherapeutics, Inc. ($AGLE) and Director in Generation Bio Co. ($GBIO) and Director in Kaleido Biosciences, Inc. ($KLDO).

Anthony Quinn in Generation Bio Co.

Trading Symbol: GBIO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Anthony Quinn: Director
Holdings: 72,837 shares
Latest Transaction: Jun 18 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Anthony Quinn in Generation Bio Co.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AGLE, GBIO, KLDO, GEVA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 18 2020	GBIO	Generation Bio Co.	Quinn Anthony G.	Director	Option Exercise	C	0.00	53,654	0	0
Jun 18 2020	GBIO	Generation Bio Co.	Quinn Anthony G.	Director	Buy	C	0.00	30,376	0	72,837	42.5 K to 72.8 K (+71.54 %)
Jun 15 2020	GBIO	Generation Bio Co.	Quinn Anthony G.	Director	Option Exercise	A	19.00	52,000	988,000	52,000

Page: 1